Oncology Institute, Inc. Files 8-K with Material Agreement
Ticker: TOIIW · Form: 8-K · Filed: Mar 27, 2025 · CIK: 1799191
| Field | Detail |
|---|---|
| Company | Oncology Institute, Inc. (TOIIW) |
| Form Type | 8-K |
| Filed Date | Mar 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, financial-reporting
TL;DR
TOI filed an 8-K on 3/26/25 detailing a material agreement and equity sales.
AI Summary
On March 26, 2025, The Oncology Institute, Inc. entered into a Material Definitive Agreement. The company also reported on unregistered sales of equity securities and filed financial statements and exhibits. Oncology Institute, Inc. was formerly known as DFP Healthcare Acquisitions Corp. until January 8, 2020.
Why It Matters
This 8-K filing indicates significant corporate activity, including a material definitive agreement and the disclosure of equity transactions, which could impact the company's financial structure and future operations.
Risk Assessment
Risk Level: medium — The filing involves material definitive agreements and unregistered sales of equity, which can introduce financial and operational risks.
Key Players & Entities
- Oncology Institute, Inc. (company) — Registrant
- DFP Healthcare Acquisitions Corp. (company) — Former Company Name
- March 26, 2025 (date) — Date of Report
- January 8, 2020 (date) — Date of Name Change
FAQ
What is the nature of the Material Definitive Agreement entered into by The Oncology Institute, Inc. on March 26, 2025?
The filing indicates that The Oncology Institute, Inc. entered into a Material Definitive Agreement on March 26, 2025, but the specific details of this agreement are not provided in the provided text.
What information is disclosed regarding unregistered sales of equity securities?
The 8-K filing states that there were unregistered sales of equity securities, but the specific details, amounts, or terms of these sales are not detailed in the provided excerpt.
What financial statements and exhibits are included with this filing?
The filing mentions that financial statements and exhibits are included, but the content of these documents is not specified in the provided text.
When did The Oncology Institute, Inc. change its name from DFP Healthcare Acquisitions Corp.?
The Oncology Institute, Inc. changed its name from DFP Healthcare Acquisitions Corp. on January 8, 2020.
What is the primary business of The Oncology Institute, Inc. based on its SIC code?
Based on its Standard Industrial Classification (SIC) code [8011], The Oncology Institute, Inc. is involved in Services - Offices & Clinics of Doctors of Medicine.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 27, 2025 regarding Oncology Institute, Inc. (TOIIW).